Arrowhead Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2010 Sep2011 Sep2012 Sep2013 Sep2014 Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Revenue & cost
Revenue 0.30M0.15M0.29M0.17M0.38M0.16M31.41M16.14M168.80M87.99M138.29M243.23M240.74M3.55M829.45M
Gross Profit 0.30M0.15M0.29M0.17M0.38M0.16M31.41M16.14M168.80M87.99M138.29M243.23M240.74M3.55M829.45M
Operating items
Amortization - Intangibles 0.24M0.24M
Research & Development 0.53M3.28M5.39M8.71M23.14M47.27M62.12M50.90M52.97M81.05M128.88M206.34M297.31M353.19M505.87M607.16M
Selling, General & Administrative 2.49M3.80M6.44M3.49M5.89M7.93M23.59M17.50M19.11M26.56M52.28M80.98M124.43M92.55M98.76M123.94M
Other Operating Expenses 2.81M3.05M9.41M-1.42M24.42M41.16M-3.81M
Operating Expenses 5.83M10.13M21.24M24.88M53.45M96.36M81.90M68.40M72.08M107.61M181.15M287.32M421.74M445.74M604.63M731.10M
Operating Income -5.83M-9.83M-21.09M-24.59M-53.28M-95.97M-81.74M-37.00M-55.94M61.19M-93.16M-149.04M-178.51M-205.00M-601.08M98.35M
EBIT -5.83M-9.83M-21.09M-24.59M-53.28M-95.97M-81.74M-37.00M-55.94M61.19M-93.16M-149.04M-178.51M-205.00M-601.08M98.35M
Non-operating items
Non Operating Investment Income -0.26M-0.06M
Interest & Investment Income -0.10M0.65M0.73M0.27M0.42M1.05M6.96M9.19M6.12M5.03M15.30M22.72M37.30M
Other Non Operating Income 1.76M1.13M1.58M-5.30M-6.03M2.87M-0.30M1.31M0.43M-0.58M2.07M0.77M1.54M-1.75M5.26M
Non Operating Income 1.52M1.05M-1.02M-7.11M-5.44M4.04M0.06M2.62M1.49M6.96M8.61M8.19M5.80M1.54M-11.38M-46.81M
Net income details
EBT -4.31M-8.79M-22.11M-31.70M-58.72M-91.94M-81.72M-34.38M-54.45M68.15M-84.55M-140.85M-172.71M-206.49M-612.46M51.53M
Tax Provisions 0.01M0.00M0.00M0.00M0.00M0.17M0.00M0.00M3.79M2.78M-2.77M21.42M
Profit After Tax -6.96M-8.79M-22.11M-31.70M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Equity Income -0.22M-0.16M-0.24M-0.64M-0.08M
Income from Non-Controlling Interests -1.18M-0.36M-0.98M-0.56M-0.10M-0.43M-4.00M-10.20M31.75M
Income from Continuing Operations -4.31M-8.79M-22.11M-31.70M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Consolidated Net Income -2.65M5.29M-0.00M-0.00M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Income towards Parent Company -2.65M5.29M-0.00M-0.00M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Net Income towards Common Stockholders -2.65M5.29M-0.00M-0.00M-58.73M-91.94M-81.72M-34.38M-54.45M67.97M-84.55M-140.85M-176.49M-209.28M-609.69M30.11M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 7.09M7.18M11.31M31.54M52.91M59.50M60.75M74.77M88.02M95.51M102.29M104.26M105.85M107.19M124.32M138.26M
Shares Outstanding (Diluted Average) 6.43M7.83M73.90M83.64M98.61M100.72M103.75M105.43M106.75M119.78M133.76M
EBITDA -5.83M-9.83M-21.09M-31.14M-58.63M-92.08M-81.58M-34.35M-54.51M67.61M-84.14M-140.94M-176.56M-212.36M-601.72M31.81M
Tax Rate 0.26%0.45%41.56%